Literature DB >> 17634425

Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis.

Kirsteen H Maclean1, Michael B Kastan, John L Cleveland.   

Abstract

Myc oncoproteins are commonly activated in malignancies and are sufficient to provoke many types of cancer. However, the critical mechanisms by which Myc contributes to malignant transformation are not clear. DNA damage seems to be an important initiating event in tumorigenesis. Here, we show that although Myc does not directly induce double-stranded DNA breaks, it does augment activation of the Atm/p53 DNA damage response pathway, suggesting that Atm may function as a guardian against Myc-induced transformation. Indeed, we show that Atm loss augments Myc-induced lymphomagenesis and impairs Myc-induced apoptosis, which normally harnesses Myc-driven tumorigenesis. Surprisingly, Atm loss also augments the proliferative response induced by Myc, and this augmentation is associated with enhanced suppression of the expression of the cyclin-dependent kinase inhibitor p27(Kip1). Therefore, regulation of cell proliferation and p27(Kip1) seems to be a contributing mechanism by which Atm holds tumor formation in check.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634425     DOI: 10.1158/1541-7786.MCR-07-0058

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  27 in total

1.  MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.

Authors:  Russell Moser; Masafumi Toyoshima; Kristin Robinson; Kay E Gurley; Heather L Howie; Jerry Davison; Martin Morgan; Christopher J Kemp; Carla Grandori
Journal:  Mol Cancer Res       Date:  2012-02-01       Impact factor: 5.852

Review 2.  Facilitating replication under stress: an oncogenic function of MYC?

Authors:  Steffi Herold; Barbara Herkert; Martin Eilers
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

3.  ATM couples replication stress and metabolic reprogramming during cellular senescence.

Authors:  Katherine M Aird; Andrew J Worth; Nathaniel W Snyder; Joyce V Lee; Sharanya Sivanand; Qin Liu; Ian A Blair; Kathryn E Wellen; Rugang Zhang
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

4.  Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.

Authors:  Hikmet G Tanyildiz; Handan Dincaslan; Gulsan Yavuz; Emel Unal; Aydan Ikinciogulları; Figen Dogu; Nurdan Tacyildiz
Journal:  J Clin Immunol       Date:  2016-08-04       Impact factor: 8.317

5.  Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.

Authors:  Alice Nemajerova; Oleksi Petrenko; Lorenz Trümper; Gustavo Palacios; Ute M Moll
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

6.  Cdk2 suppresses cellular senescence induced by the c-myc oncogene.

Authors:  Stefano Campaner; Mirko Doni; Per Hydbring; Alessandro Verrecchia; Lucia Bianchi; Domenico Sardella; Thomas Schleker; Daniele Perna; Susanna Tronnersjö; Matilde Murga; Oscar Fernandez-Capetillo; Mariano Barbacid; Lars-Gunnar Larsson; Bruno Amati
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

7.  Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression.

Authors:  Alejo Efeyan; Matilde Murga; Barbara Martinez-Pastor; Ana Ortega-Molina; Rebeca Soria; Manuel Collado; Oscar Fernandez-Capetillo; Manuel Serrano
Journal:  PLoS One       Date:  2009-05-07       Impact factor: 3.240

8.  Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage.

Authors:  Lina Guerra; Ami Albihn; Susanna Tronnersjö; Qinzi Yan; Riccardo Guidi; Bo Stenerlöw; Torsten Sterzenbach; Christine Josenhans; James G Fox; David B Schauer; Monica Thelestam; Lars-Gunnar Larsson; Marie Henriksson; Teresa Frisan
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

9.  Tumor suppression by p53 in the absence of Atm.

Authors:  S Lawrence Bailey; Kay E Gurley; Kyung Hoon-Kim; Karen S Kelly-Spratt; Christopher J Kemp
Journal:  Mol Cancer Res       Date:  2008-06-26       Impact factor: 5.852

10.  Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases.

Authors:  Yunyuan V Wang; Mathias Leblanc; Mark Wade; Aart G Jochemsen; Geoffrey M Wahl
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.